Skip to content

Continuing Care Following Drug Abuse Treatment: Linkage With Primary Care

Continuing Care Following Drug Abuse Treatment: Linkage With Primary Care

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01621711
Acronym
Linkage
Enrollment
504
Registered
2012-06-18
Start date
2011-03-31
Completion date
2025-12-31
Last updated
2024-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol Abuse, Substance Abuse, Substance, Addiction, Substance Dependence

Keywords

substance abuse, Substance Dependence, Substance, addiction, Alcohol Abuse, prevention and control, preventative health services, patient centered care

Brief summary

This component of a larger Center of Research Excellence Grant improves treatment for drug abuse by developing effective linkages between specialty drug treatment and primary health care.

Detailed description

This is a longitudinal two-arm quasi-experimental 3-month alternating off/on design over a 30 month period in which, after a random start, the Linkage condition alternately is added to Usual Care in the Chemical Dependency (CD) clinic and then removed. We compare Usual Care to Usual Care plus Linkage. Follow-up interviews will be conducted at 6, 12 and 24 months. The Linkage intervention includes Usual Care plus 1) sessions on activation regarding overall health behaviors and on selecting a Primary Care physician and communicating with him/her, and 2) a linkage phone call (and/or a facilitated email) with the patient, clinician, and Primary Care physician. The intervention aims to place drug abuse problems in the context of overall health and health care and to activate patients to increase involvement in their own health care.

Interventions

BEHAVIORALLinkage patient activation intervention

Usual Care plus Linkage encompassed Usual Care with the exception that the six 45-min Linkage patient activation education groups replaced the six 45-min Usual Care medical education groups, plus a linkage phone call (and/or a facilitated email) with the patient, clinician, and Primary Care physician. The patient activation intervention components -- 1) six 45-min Linkage sessions on activation regarding overall health behaviors and 2) a linkage phone call (and/or a facilitated email) with the patient, clinician, and PC physician -- were delivered by a clinical psychologist.

Sponsors

Kaiser Foundation Research Institute
CollaboratorOTHER
Kaiser Permanente
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Research participants will be adult patients at the Kaiser Permanente San Francisco Chemical Dependency Recovery Program, who have completed 2 weeks of treatment.

Exclusion criteria

* Patients with a diagnosis of dementia, mental retardation, or who are actively psychotic or suicidal will be excluded by their clinician.

Design outcomes

Primary

MeasureTime frameDescription
patient activation measure6 months post baselineMeasured by Patient Activation Measure (PAM) from interview data
patient engagement in health care (including patient portal use, familiarity and satisfaction with Primary Care physician, and CD treatment length of stay)6 months post baselineMeasured by data from interviews and Electronic Health Record (EHR)
Substance use and mental health outcomes6 months post baselineMeasures include past 30-day alcohol, drug and total abstinence; Patient Health Questionnaire (PHQ-9) and Addiction Severity Index using interview data

Secondary

MeasureTime frameDescription
patient activation measure at 12 and 24 months12 and 24 months post baselineMeasured by Patient Activation Measure (PAM) from interview data
Health care utilization and cost12 and 24 months post baselineMeasured by data from interviews and adminstrative data
patient engagement in health care at 12 and 24 months12 and 24 months post baselineMeasured by data from interviews and Electronic Health Record (EHR)
Substance use and mental health outcomes at 12 and 24 months12 and 24 months post baselineMeasures include past 30-day alcohol, drug and total abstinence; Patient Health Questionnaire (PHQ-9) and Addiction Severity Index using interview data

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026